New York hub to improve addiction treatment and care
NIDA Clinical Trials Network: New York Node - Renewal-GY24
This program runs clinical trials in New York to find better treatments and ways to deliver care for people with substance use disorders.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11261209 on NIH RePORTER |
What this research studies
This New York Node runs and supports clinical trials that test new medications, behavioral therapies, and ways to deliver care for people with substance use disorders. It partners with NYU, Columbia, Rutgers, Einstein-Montefiore, large health systems, and community organizations to enroll patients and carry out multi-site studies. The team also uses existing patient data and implementation science to figure out how to make effective treatments easier to use in real-world clinics. If you join at a participating clinic, you might be asked to try a new treatment, fill out surveys, or provide samples for research.
Who could benefit from this research
Good fit: Ideal candidates are people with substance use disorders who receive care at participating hospitals, clinics, or community programs in the New York metropolitan area.
Not a fit: People without substance use disorders or those who cannot access a participating site are unlikely to benefit directly from this program.
Why it matters
Potential benefit: If successful, this program could speed development and delivery of more effective addiction treatments and make them easier to access in clinical settings.
How similar studies have performed: The Clinical Trials Network and the New York Node have previously led many multi-site trials and ancillary studies that have informed and improved addiction care.
Where this research is happening
New York, United States
- New York University School of Medicine — New York, United States (Active)
Researchers
- Principal investigator: Mcneely, Jennifer — New York University School of Medicine
- Study coordinator: Mcneely, Jennifer
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.